---
id: sgobs.consumer.proposed-chp-regulation-2026.consultation
kind: observation
title: "拟议消费品安全法规定的咨询及过渡时间表"
url: https://ik.sg/zh/knowledge/observation/sgobs.consumer.proposed-chp-regulation-2026.consultation
language: zh-Hans
evidence_status: provisional
collection_as_of: 2026-11-22
---

# 拟议消费品安全法规定的咨询及过渡时间表

据描述，中药产品自 2027 年初起适用另一套框架；咨询提案本身并非已颁布的法律。

## 记录详情

- **分母口径:** Proposed framework and consultation scope; not enacted obligations for every product or final implementation rules
- **地理范围:** [新加坡](https://ik.sg/zh/knowledge/geography/sg.geo.country.singapore)
- **数值类型:** observation
- **指标:** proposed chp regulation 2026 consultation (`sgmetric.consumer.proposed-chp-regulation-2026-consultation`)
- **适用人群:** Complementary health products in the consulted scope, including health supplements, specified traditional medicines, homeopathic medicines, medicated oils, balms, plasters and topical antiseptics
- **发布日期:** 2026-07-01
- **统计期间:** HSA consultation notice dated 1 July 2026
- **来源版本:** HSA proposed CHP regulatory framework consultation
- **状态:** provisional
- **单位:** consultation window and proposed policy timeline
- **数值:** Consultation 1–29 July 2026; HSA intends to move remaining CHP medicinal-product controls from the Medicines Act to the Health Products Act by end-2028

## 资料来源

- [https://www.hsa.gov.sg/announcements/consultation-proposed-regulation-complementary-health-products/](https://www.hsa.gov.sg/announcements/consultation-proposed-regulation-complementary-health-products/) — 访问日期 2026-09-02

## 探索关联

- 主题: [拟议辅助健康产品法规](https://ik.sg/zh/knowledge/topic/sgtopic.consumer.proposed-complementary-health-products-regulation-2026)
- 地点: [新加坡](https://ik.sg/zh/knowledge/geography/sg.geo.country.singapore)

日期表示本记录的统计期间与适用范围。核验日期并不代表规则目前已经生效。 知识库持续扩充中。发布数量表示现有内容，并不代表已覆盖新加坡的全部知识。
